EnVVeno Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . enVVeno Medical Corp
NVNO Stock  USD 2.85  0.11  3.72%   
EnVVeno Medical financial statements provide useful quarterly and yearly information to potential enVVeno Medical Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on EnVVeno Medical financial statements helps investors assess EnVVeno Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting EnVVeno Medical's valuation are summarized below:
Market Capitalization
51.9 M
Earnings Share
(1.27)
We have found one hundred twenty available fundamental signals for enVVeno Medical Corp, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to verify EnVVeno Medical's prevailing fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. As of the 18th of March 2025, Market Cap is likely to grow to about 59.7 M. Also, Enterprise Value is likely to grow to about 57.7 M

EnVVeno Medical Total Revenue

0.0

Check EnVVeno Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EnVVeno Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 387 K, Interest Expense of 224.9 K or Other Operating Expenses of 30.5 M, as well as many indicators such as Price To Sales Ratio of 262, Dividend Yield of 0.0 or PTB Ratio of 1.29. EnVVeno financial statements analysis is a perfect complement when working with EnVVeno Medical Valuation or Volatility modules.
  
Check out the analysis of EnVVeno Medical Correlation against competitors.

EnVVeno Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets23.9 M45 M16 M
Slightly volatile
Short and Long Term Debt Total1.2 M1.1 M1.5 M
Slightly volatile
Other Current Liabilities837.8 K725 K1.4 M
Slightly volatile
Total Current Liabilities2.2 M2.1 M3.3 M
Slightly volatile
Property Plant And Equipment Net1.1 M1.2 M708.5 K
Slightly volatile
Accounts Payable715.3 K1 M796.7 K
Pretty Stable
Cash1.7 M1.8 M5.6 M
Pretty Stable
Non Current Assets Total1.8 M1.2 M1.5 M
Slightly volatile
Non Currrent Assets Other26.5 K27.9 K128.5 K
Pretty Stable
Cash And Short Term Investments21.8 M43.2 M14.3 M
Slightly volatile
Common Stock Shares Outstanding18 M17.1 M4.6 M
Slightly volatile
Liabilities And Stockholders Equity23.9 M45 M16 M
Slightly volatile
Non Current Liabilities Total1.4 M700 K1.7 M
Slightly volatile
Other Current Assets337.8 K581 K275.4 K
Slightly volatile
Other Stockholder Equity99.1 M194 M69 M
Slightly volatile
Total Liabilities3.6 M2.8 M5 M
Slightly volatile
Total Current Assets22.1 M43.7 M14.5 M
Slightly volatile
Short Term Debt635 K364 K1.1 M
Slightly volatile
Intangible Assets781.6 K599.8 K819.9 K
Slightly volatile
Common Stock82.1785.5105
Slightly volatile
Net Receivables27.4 K28.8 K100.7 K
Slightly volatile
Deferred Long Term Liabilities704.5 K792.6 K864.2 K
Slightly volatile
Short and Long Term Debt267.4 K281.4 K1.5 M
Slightly volatile
Property Plant Equipment968.9 K599.1 K471.3 K
Slightly volatile
Capital Lease Obligations1.4 M1.1 M1 M
Slightly volatile
Property Plant And Equipment Gross2.7 M2.4 M1.9 M
Slightly volatile
Capital Surpluse116.2 M130.7 M142.5 M
Slightly volatile
Non Current Liabilities Other1.1 M1.3 M1.4 M
Slightly volatile

EnVVeno Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization387 K253 K277.1 K
Slightly volatile
Interest Expense224.9 K236.7 K545 K
Very volatile
Other Operating Expenses30.5 M29 M10.6 M
Slightly volatile
Total Operating Expenses14 M23.8 M9.2 M
Slightly volatile
Selling General Administrative9.8 M11.6 M7.5 M
Slightly volatile
Research Development6.9 M12.2 M3.8 M
Slightly volatile
Reconciled Depreciation426.4 K528 K281.4 K
Slightly volatile
Interest Income408.4 K389 K104.2 K
Slightly volatile
Non Operating Income Net Other81.6 K91.8 K100.1 K
Slightly volatile

EnVVeno Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow3.4 M3.6 M5.2 M
Slightly volatile
Depreciation372 K528 K273.8 K
Slightly volatile
Capital Expenditures35.1 K37 K96.6 K
Slightly volatile
End Period Cash Flow1.7 M1.8 M5.6 M
Pretty Stable
Stock Based Compensation3.7 M4.1 M2.7 M
Slightly volatile
Net Borrowings267.4 K281.4 K1.8 M
Slightly volatile
Change To Netincome10.9 M10.4 M3.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio262250181
Slightly volatile
Days Sales Outstanding68.1572.0574.7454
Slightly volatile
Average Payables822.3 K1.2 M967 K
Slightly volatile
Stock Based Compensation To Revenue28.4927.1314.5128
Slightly volatile
Capex To Depreciation0.06660.07010.4019
Very volatile
EV To Sales249237176
Slightly volatile
Inventory Turnover7.138.028.746
Slightly volatile
Days Of Inventory On Hand32.7636.8540.1817
Slightly volatile
Payables Turnover1.211.150.5635
Slightly volatile
Research And Ddevelopement To Revenue66.7363.5531.3933
Slightly volatile
Capex To Revenue11.0110.485.0481
Slightly volatile
Cash Per Share2.682.51742.533
Slightly volatile
Days Payables Outstanding3123281.2 K
Slightly volatile
Intangibles To Total Assets0.20.220.3817
Slightly volatile
Current Ratio21.9220.87549.0325
Slightly volatile
Receivables Turnover5.85.245.3459
Slightly volatile
Capex Per Share0.00210.00220.106
Very volatile
Average Receivables36.7 K38.6 K76 K
Slightly volatile
Revenue Per Share0.05410.0570.6548
Slightly volatile
Interest Debt Per Share0.0590.06213.5355
Slightly volatile
Debt To Assets0.02250.02370.3906
Slightly volatile
Operating Cycle83.1672.0593.5991
Slightly volatile
Days Of Payables Outstanding3123281.2 K
Slightly volatile
Ebt Per Ebit1.210.91581.098
Pretty Stable
Long Term Debt To Capitalization0.0130.01470.016
Slightly volatile
Quick Ratio21.9220.87549.0298
Slightly volatile
Net Income Per E B T0.750.891.0053
Slightly volatile
Cash Ratio0.80.83722.9859
Slightly volatile
Days Of Inventory Outstanding32.7636.8540.1817
Slightly volatile
Days Of Sales Outstanding68.1572.0574.7454
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.81.00220.9241
Slightly volatile
Fixed Asset Turnover0.02920.03075.6473
Pretty Stable
Debt Ratio0.02250.02370.3906
Slightly volatile
Price Sales Ratio262250181
Slightly volatile
Asset Turnover0.00990.01050.1207
Slightly volatile

EnVVeno Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap59.7 M56.9 M27.4 M
Slightly volatile
Enterprise Value57.7 M54.9 M21.4 M
Slightly volatile

EnVVeno Fundamental Market Drivers

Cash And Short Term Investments43.2 M

EnVVeno Upcoming Events

25th of January 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
25th of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About EnVVeno Medical Financial Statements

EnVVeno Medical investors utilize fundamental indicators, such as revenue or net income, to predict how EnVVeno Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-384.3 K-365.1 K
Cost Of Revenue491.4 K358.6 K
Stock Based Compensation To Revenue 27.13  28.49 
Research And Ddevelopement To Revenue 63.55  66.73 
Capex To Revenue 10.48  11.01 
Revenue Per Share 0.06  0.05 
Ebit Per Revenue(282.51)(268.39)
When determining whether enVVeno Medical Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EnVVeno Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Envveno Medical Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Envveno Medical Corp Stock:
How To Invest In EnVVeno
Details
Is EnVVeno Stock a good investment?
Details
What is EnVVeno Medical's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of EnVVeno Medical Correlation against competitors.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.27)
Return On Assets
(0.32)
Return On Equity
(0.49)
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY